International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(24), С. 15632 - 15632
Опубликована: Дек. 9, 2022
Inflammatory
Bowel
Disease
(IBD)
is
a
chronic
gastrointestinal
disorder
characterized
by
periods
of
activity
and
remission.
IBD
includes
Crohn’s
disease
(CD)
ulcerative
colitis
(UC),
even
though
has
not
been
considered
as
heritable
disease,
there
are
genetic
variants
associated
with
increased
risk
for
the
disease.
5-Hydroxytriptamine
(5-HT),
or
serotonin,
exerts
wide
range
effects
under
both
normal
pathological
conditions.
Furthermore,
Serotonin
Transporter
(SERT)
coded
Solute
Carrier
Family
6
Member
4
(SLC6A4)
gene
(located
in
17q11.1-q12
chromosome),
possesses
variants,
such
Gene
Variable
Number
Tandem
Repeat
Intron
2
(STin2-VNTR)
Serotonin-Transporter-linked
promoter
region
(5-HTTLPR),
which
have
an
influence
over
functionality
SERT
re-uptake
bioavailability
serotonin.
The
intestinal
microbiota
crucial
actor
human
gut
physiology,
exerting
on
function,
inflammatory
processes.
As
consequence
abnormal
serotonin
signaling
function
these
processes,
use
selective
inhibitors
(SSRIs)
seen
to
improve
extraintestinal
manifestations,
depression
anxiety.
aim
this
study
integrate
scientific
data
linking
regulator
re-uptake,
well
its
role
pathogenesis
IBD.
We
performed
narrative
review,
including
literature
search
PubMed
database
review
original
articles
(no
date
restriction),
information
about
SLC6A4
obtained
from
Ensembl
website.
Scientific
evidence
vitro,
vivo,
clinical
trials
regarding
reuptake
adjuvant
therapy
patients
also
discussed.
A
total
194
were
used
between
reviews,
vitro
studies,
trials.
ACS Chemical Neuroscience,
Год журнала:
2023,
Номер
14(10), С. 1717 - 1763
Опубликована: Май 8, 2023
Gut
microbiota
includes
a
vast
collection
of
microorganisms
residing
within
the
gastrointestinal
tract.
It
is
broadly
recognized
that
gut
and
brain
are
in
constant
bidirectional
communication,
which
its
metabolic
production
major
component,
form
so-called
microbiome–brain
axis.
Disturbances
homeostasis
caused
by
imbalance
their
functional
composition
activities,
known
as
dysbiosis,
cause
dysregulation
these
pathways
trigger
changes
blood–brain
barrier
permeability,
thereby
causing
pathological
malfunctions,
including
neurological
disorders.
In
turn,
can
affect
structure
function
through
autonomic
nervous
system
regulating
motility,
intestinal
transit
secretion,
permeability.
Here,
we
examine
data
from
CAS
Content
Collection,
largest
published
scientific
information,
analyze
publication
landscape
recent
research.
We
review
advances
knowledge
related
to
human
microbiome,
complexity
functionality,
communication
with
central
system,
effect
axis
on
mental
health.
discuss
correlations
between
various
diseases,
specifically
also
explore
metabolites
regard
impact
associated
diseases.
Finally,
assess
clinical
applications
gut-microbiota-related
substances
development
pipelines.
hope
this
serve
useful
resource
understanding
current
emerging
field
an
effort
further
solving
remaining
challenges
fulfilling
potential.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(4), С. 565 - 565
Опубликована: Апрель 9, 2023
The
gut
microbiota
is
critical
for
maintaining
human
health
and
the
immunological
system.
Several
neuroscientific
studies
have
shown
significance
of
in
developing
brain
systems.
are
interconnected
a
bidirectional
relationship,
as
research
on
microbiome–gut–brain
axis
shows.
Significant
evidence
links
anxiety
depression
disorders
to
community
microbes
that
live
gastrointestinal
Modified
diet,
fish
omega-3
fatty
acid
intake,
macro-
micro-nutrient
prebiotics,
probiotics,
synbiotics,
postbiotics,
fecal
transplantation,
5-HTP
regulation
may
all
be
utilized
alter
treatment
approach.
There
few
preclinical
clinical
effectiveness
reliability
various
therapeutic
approaches
anxiety.
This
article
highlights
relevant
association
with
different
possibilities
modification.
Nutrients,
Год журнала:
2023,
Номер
15(6), С. 1496 - 1496
Опубликована: Март 20, 2023
There
is
growing
interest
in
the
role
that
intestinal
microbiota
and
related
autoimmune
processes
may
have
genesis
presentation
of
some
psychiatric
diseases.
An
alteration
communication
microbiota-gut-brain
axis,
which
constitutes
a
communicative
model
between
central
nervous
system
(CNS)
gastro-enteric
tract,
has
been
identified
as
one
possible
causes
The
purpose
this
narrative
review
to
describe
evidence
supporting
gut
diseases
impact
diet
on
mental
health.
Change
composition
could
determine
an
increase
permeability
barrier,
leading
cytokine
storm.
This
trigger
systemic
inflammatory
activation
immune
response:
series
events
repercussions
release
neurotransmitters,
altering
activity
hypothalamic-pituitary-adrenal
reducing
presence
trophic
brain
factors.
Although
disorders
seem
be
connected,
more
effort
needed
understand
potential
causative
mechanisms
underlying
interactions
these
systems.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Год журнала:
2023,
Номер
128, С. 110861 - 110861
Опубликована: Сен. 9, 2023
There
is
a
lot
of
evidence
establishing
that
nervous
system
development
related
to
the
composition
and
functions
gut
microbiome.
In
addition,
central
(CNS)
controls
imbalance
intestinal
microbiota,
constituting
bidirectional
communication
system.
At
present,
various
gut-brain
crosstalk
routes
have
been
described,
including
immune,
endocrine
neural
circuits
via
vagal
pathway.
Several
empirical
data
associated
microbiota
alterations
(dysbiosis)
with
neuropsychiatric
diseases,
such
as
Alzheimer's
disease,
autism
Parkinson's
other
psychological
disorders,
like
anxiety
depression.
Fecal
transplantation
(FMT)
therapy
has
shown
can
transfer
behavioral
features
recipient
animals,
which
provides
strong
establish
causal-effect
relationship.
Interventions,
based
on
prebiotics,
probiotics
or
synbiotics,
demonstrated
an
important
influence
neurological
disorders
by
synthesis
neuroactive
compounds
interact
regulation
inflammatory
processes.
Further
research
needed
demonstrate
dysbiosis
psychiatric
how
microbiota-based
interventions
may
be
used
potential
therapeutic
tools.
Molecules,
Год журнала:
2023,
Номер
28(7), С. 3213 - 3213
Опубликована: Апрель 4, 2023
Depression
is
a
common
and
complex
mental
emotional
disorder
that
causes
disability,
morbidity,
quite
often
mortality
around
the
world.
closely
related
to
several
physical
metabolic
conditions
causing
depression.
Studies
have
indicated
there
relationship
between
intestinal
microbiota
brain,
known
as
gut–brain
axis.
While
this
microbiota–gut–brain
connection
disturbed,
dysfunctions
of
immune
system,
endocrine
gastrointestinal
tract
occur.
Numerous
studies
show
dysbiosis
characterized
by
abnormal
dysfunction
axis
could
be
direct
cause
disorders.
Traditional
treatment
depression
includes
psychotherapy
pharmacotherapy,
it
mainly
targets
brain.
However,
restoration
functions
via
using
probiotics,
their
metabolites,
prebiotics,
healthy
diet
may
alleviate
depressive
symptoms.
Administration
probiotics
labeled
psychobiotics
metabolites
metabiotics,
especially
an
adjuvant
antidepressants,
improves
It
new
approach
prevention,
management,
illnesses,
particularly
major
For
effectiveness
antidepressant
therapy,
should
administered
at
dose
higher
than
1
billion
CFU/day
for
least
8
weeks.
JAMA Network Open,
Год журнала:
2023,
Номер
6(1), С. e2253570 - e2253570
Опубликована: Янв. 30, 2023
Importance
Recurrent
Clostridioides
difficile
infection
(CDI)
is
a
debilitating
disease
leading
to
poor
health-related
quality
of
life
(HRQOL),
loss
productivity,
anxiety,
and
depression.
The
potential
association
treatment
with
HRQOL
has
not
been
well
evaluated.
Objectives
To
explore
the
SER-109
compared
placebo
on
in
patients
recurrent
CDI
up
week
8.
Design,
Setting,
Participants
This
study
was
secondary
analysis
randomized,
double-blind,
placebo-controlled
trial
that
took
place
at
56
sites
US
Canada
from
July
2017
April
2020
included
182
randomized
or
groups.
Interventions
(4
capsules
once
daily
for
3
days)
following
antibiotics
CDI.
Main
Outcomes
Measures
Exploratory
using
specific
Quality
Life
Survey
(Cdiff32)
assessed
baseline,
1,
Results
In
this
study,
(109
[59.9%]
female;
mean
age,
65.5
[16.5]
years)
were
(89
[48.9%])
(93
[51.1%])
groups
primary
exploratory
analyses.
Baseline
Cdiff32
scores
similar
between
(52.0
[18.3]
vs
52.8
[18.7],
respectively).
proportion
overall
improvement
baseline
total
score
higher
arm
than
1
(49.4%
26.9%;
P
=
.012)
8
(66.3%
48.4%;
.001).Greater
improvements
physical
domain
subdomain
observed
group
as
early
continued
Among
group,
primarily
nonrecurrent
while
reported
HRQOL,
regardless
clinical
outcome.
Conclusions
Relevance
phase
trial,
SER-109,
an
investigational
microbiome
therapeutic
associated
rapid
steady
through
weeks,
important
patient-reported
Trial
Registration
ClinicalTrials.gov
Identifier:
NCT03183128
Frontiers in Psychiatry,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 23, 2023
The
need
to
find
new
therapeutic
interventions
in
patients
diagnosed
with
psychiatric
disorders
is
supported
by
the
data
suggesting
high
rates
of
relapse,
chronic
evolution,
resistance,
or
lack
adherence
and
disability.
use
pre-,
pro-,
synbiotics
as
add-ons
management
has
been
explored
a
way
augment
efficacy
psychotropics
improve
chances
for
these
reach
response
remission.
This
systematic
literature
review
focused
on
tolerability
psychobiotics
main
categories
it
conducted
through
most
important
electronic
databases
clinical
trial
registers,
using
PRISMA
2020
guidelines.
quality
primary
secondary
reports
was
assessed
criteria
identified
Academy
Nutrition
Diabetics.
Forty-three
sources,
mostly
moderate
quality,
were
reviewed
detail,
regarding
assessed.
Studies
exploring
effects
mood
disorders,
anxiety
schizophrenia
spectrum
substance
eating
attention
deficit
hyperactivity
disorder
(ADHD),
neurocognitive
autism
(ASD)
included.
overall
good,
but
evidence
support
their
specific
mixed.
There
have
favor
probiotics
ADHD,
ASD,
also
association
selenium
disorders.
In
several
domains,
research
still
an
early
phase
development,
e.g.,
(only
three
preclinical
studies
being
found)
(one
identified).
Although
no
well-defined
recommendation
could
yet
be
formulated
product
there
encouraging
further
research,
especially
if
identification
sub-populations
that
may
benefit
from
this
intervention.
Several
limitations
field
should
addressed,
i.e.,
majority
finalized
trials
are
short
duration,
inherent
heterogeneity
diversity
Philae
prevents
generalizability
results
studies.